Roche promotes from within to replace pharma head
BioPharma
Source: biopharmadive.com
📰 Genentech News
Page 208 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
CureVac Welcomes Myriam Mendila as New Chief Development Officer
Dr. Mendila joins CureVac as Chief Development Officer with more than 20 years of global industry experienceTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 1, 2023 / CureVac N.V. (Nasdaq:CVAC)
Source: finanznachrichten.de
Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: European Commission approves label expansion of Roche's Hemlibra to include people with moderate haemophilia A in the EU
Investegate announcements from F. Hoffmann-La Roche Ltd, European Commission approves label expansion of Roche’s Hemlibra to include people with moderate haemophilia A in the EU
United States Levi Garraway Loren Kalm Nathalie Altermatt Roche Hemlibra Chugai Pharmaceutical Co Ltd
Source: investegate.co.uk
Cities seek continued tax incentives, more state aid for public works
Officials from Oregon’s 241 cities want state legislators to continue tax breaks and increase aid for public works, both of which they say they need to maintain business investment and
Oregon State University United States Umatilla County Portland State University Portland Community College Tina Kotek
Source: hermistonherald.com
Investegate |CureVac Announcements | CureVac: CureVac Welcomes Myriam Mendila as New Chief Development Officer
Investegate announcements from CureVac, CureVac Welcomes Myriam Mendila as New Chief Development Officer
Source: investegate.co.uk
The corporate cafeteria is pronounced dead
The corporate cafeteria can be an especially lonely place these days...
Source: khaleejtimes.com
F. Hoffmann-La Roche Ltd: European Commission approves label expansion of Roche's Hemlibra to include people with moderate haemophilia A in the EU
Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient prophylactic treatment option for people with moderate haemophilia AModerate haemophilia
Source: finanznachrichten.de
Ahead of Black History Month, Genentech focuses next installment of #MSVisibility on barriers to care for Black patients
Jennifer Kim, VP and head of neuroimmunology at Genentech Marketing, spoke with MM+M about the expectations for Breaking Barriers.
Source: mmm-online.com
Etrolizumab (RG7413) - IBD News Today
Etrolizumab (RG7413) is a monoclonal antibody, now in Phase 3 tests, being developed by Genentech to treat both ulcerative colitis and Crohn’s disease.
Source: ibdnewstoday.com
Prevent Blindness Provides Free Resources for February's Age-related Macular Degeneration (AMD) and Low Vision Awareness Month
CHICAGO (PRWEB) January 30, 2023 -- As part of February’s Age-related Macular Degeneration (AMD) and Low Vision Awareness Month, Prevent Blindness, the
United States Jeff Todd Centers For Disease Center At Preventblindness Apellis Pharmaceuticals Inc Eye Health Surveillance System
Source: prweb.com